Qi Guo, Master of Science, is graduated from the University of Pennsylvania and now working as a researcher in Dr. Seyfried’s lab. Qi’s project is to develop a label-free targeted parallel reaction monitoring (PRM) assay to address what RNA binding proteins co-aggregate with Tau in early asymptomatic (AsymAD) and symptomatic stages of AD. Qi is also working as part of the Proteomic core, which provides protein analytical services by cutting edge mass spectrometry.